Role of left ventricular diastolic dysfunction in predicting atrial fibrillation recurrence after successful electrical cardioversion

Journal of Atrial Fibrillation

Volumn 5, Issue 4, 2012, Pages 87-94

  Melduni, Rowlens M ^a   Cullen, Michael W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE;

AORTA; AORTA PRESSURE; CARDIOVERSION; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MUSCLE FIBRIL; PRIMARY PREVENTION; RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; SINUS RHYTHM; TISSUE DOPPLER IMAGING;

EID: 84875490602     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
2. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13:1110-7.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
5. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998;158:229-34. (Pubitemid 28123885)
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-4. (Pubitemid 17138836)
7. Melduni RM, Malouf JF, Chandrasekaran K et al. New insights into the predictors of left atrial stunning after successful direct-current cardioversion of atrial fibrillation and flutter. J Am Soc Echocardiogr 2008;21:848-54.
8. Melduni RM, Suri RM, Seward JB et al. Diastolic dysfunction in patients undergoing cardiac surgery: a pathophysiological mechanism underlying the initiation of new-onset post-operative atrial fibrillation. J Am Coll Cardiol 2011;58:953-61.
9. Caputo M, Urselli R, Capati E et al. Usefulness of left ventricular diastolic dysfunction assessed by pulsed tissue Doppler imaging as a predictor of atrial fibrillation recurrence after successful electrical cardioversion. Am J Cardiol 2011;108:698-704.
10. Aronson D, Mutlak D, Bahouth F et al. Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction. Am J Cardiol 2011;107:1738-43.
11. Bakowski D, Wozakowska-Kaplon B, Opolski G. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. Pacing and clinical electrophysiology : PACE 2009;32:745-52.
12. Hu YF, Hsu TL, Yu WC et al. The impact of diastolic dysfunction on the atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Circ J 2010;74:2074-8.
13. Lin C, Edwards C, Armstrong GP et al. Prevalence and prognostic significance of left ventricular dysfunction in patients presenting acutely with atrial fibrillation. Clin Med Insights Cardiol 2010;4:23-9.
14. Machino-Ohtsuka T, Seo Y, Tada H et al. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. Journal of cardiovascular electrophysiology 2011;22:999-1006.
15. Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ. Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. European heart journal 2012;33:904-12.
16. Ommen SR, Nishimura RA, Appleton CP et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler- catheterization study. Circulation 2000;102:1788-94.
17. Nishimura RA, Tajik AJ. Evaluation of Diastolic Filling of Left Ventricle in Health and Disease: Doppler Echocardiography Is the Clinician's Rosetta Stone. Journal of the American College of Cardiology 1997;30:8-18. (Pubitemid 27357121)
18. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB. Unlocking the Mysteries of Diastolic Function: Deciphering the Rosetta Stone 10 Years Later. Journal of the American College of Cardiology 2008;51:679-689. (Pubitemid 351221211)
19. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation 1998;98:1644-50.
20. Yamamoto K, Nishimura RA, Burnett Jr JC, Redfield MM. Assessment of left ventricular end-diastolic pressure by Doppler echocardiography: Contribution of duration of pulmonary venous versus mitral flow velocity curves at atrial contraction. Journal of the American Society of Echocardiography 1997;10:52-59. (Pubitemid 127799935)
21. Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes Jr DR, Tajik AJ. Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: A simultaneous doppler echocardiographic and cardiac catheterization study. Journal of the American College of Cardiology 1996;28:1226-1233. (Pubitemid 26376999)
22. Pelliccia A, Maron BJ, Di Paolo FM et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. Journal of the American College of Cardiology 2005;46:690-6. (Pubitemid 41132699)
23. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. The New England journal of medicine 1982;306:1018-22. (Pubitemid 12155370)
24. Boldt A, Wetzel U, Lauschke J et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004;90:400-5. (Pubitemid 38406914)
25. Khan A, Moe GW, Nili N et al. The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure. J Am Coll Cardiol 2004;43:68-76. (Pubitemid 38045918)
26. Tsang TS, Barnes ME, Bailey KR et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001;76:467-75. (Pubitemid 32423130)
27. Lam CS, Roger VL, Rodeheffer RJ et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007;115:1982-90. (Pubitemid 46625948)
28. Tsao HM, Yu WC, Cheng HC et al. Pulmonary vein dilation in patients with atrial fibrillation: detection by magnetic resonance imaging. Journal of cardiovascular electrophysiology 2001;12:809-13.
29. Chang SL, Chen YC, Chen YJ et al. Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins. Heart 2007;93:82-8.
30. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England journal of medicine 1998;339:659-66. (Pubitemid 28402090)
31. Kalifa J, Jalife J, Zaitsev AV et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 2003;108:668-71. (Pubitemid 36999249)
32. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation 1966;34:412-22.
33. Chen SA, Hsieh MH, Tai CT et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999;100:1879-86.
34. Jais P, Hocini M, Macle L et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002;106:2479-85. (Pubitemid 35278805)
35. Ortiz J, Niwano S, Abe H, Rudy Y, Johnson NJ, Waldo AL. Mapping the conversion of atrial flutter to atrial fibrillation andatrial fibrillation to atrial flutter. Insights into mechanisms. Circulation research 1994;74:882-94. (Pubitemid 24121591)
36. Sohn D-W, Song J-M, Zo J-H et al. Mitral Annulus Velocity in the Evaluation of Left Ventricular Diastolic Function in Atrial Fibrillation. Journal of the American Society of Echocardiography 1999;12:927-931. (Pubitemid 29533945)
37. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
38. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962;182:548-55.
39. Dahlin J, Svendsen P, Gadsboll N. Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a 5-year follow-up of 268 consecutive patients. Scand Cardiovasc J 2003;37:324-8. (Pubitemid 38159347)
40. Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol 2001;24:238-44. (Pubitemid 32187072)
41. Everett THt, Li H, Mangrum JM et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000;102:1454-60.
42. Healey JS, Connolly SJ, Gold MR et al. Subclinical atrial fibrillation and the risk of stroke. The New England journal of medicine 2012;366:120-9.
43. Marchese P, Bursi F, Delle Donne G et al. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2011;12:214-21.
44. Bollmann A, Husser D, Steinert R et al. Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. Journal of cardiovascular electrophysiology 2003;14:S162-5. (Pubitemid 37392998)
45. Verhorst PM, Kamp O, Welling RC, Van Eenige MJ, Visser CA. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. Am J Cardiol 1997;79:1355-9. (Pubitemid 27262061)
46. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England journal of medicine 2002;347:1825-33. (Pubitemid 35417773)
47. Raitt MH, Volgman AS, Zoble RG et al. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American heart journal 2006;151:390-6. (Pubitemid 43148983)
48. Lundstrom T, Ryden L. Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand 1988;223:53-9. (Pubitemid 18031560)
49. Elhendy A, Gentile F, Khandheria BK et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation. American Journal of Cardiology 2002;89:83-6. (Pubitemid 34066596)
50. Van Gelder IC, Crijns HJ. Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. Pacing and clinical electrophysiology : PACE 1997;20:2675-83.
51. Tsang TS, Gersh BJ, Appleton CP et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002;40:1636-44. (Pubitemid 35253642)
52. Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003;41:1036-43. (Pubitemid 36315550)
53. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9. (Pubitemid 35449471)
54. Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart 2002;87:443-8. (Pubitemid 34454585)
55. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. European heart journal 2006;27:512-8.
56. Schneider MP, Hua TA, Bohm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. Journal of the American College of Cardiology 2010;55:2299-307.
57. Dabrowski R, Borowiec A, Smolis-Bak E et al. Effect of combined spironolactone-beta-blocker +/- enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study). The American journal of cardiology 2010;106:1609-14.
58. Zhao J, Li J, Li W et al. Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. British journal of pharmacology 2010;159:1584-94.
59. Swedberg K, Zannad F, McMurray JJ et al. Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure: Results From the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) Study. Journal of the American College of Cardiology 2012;59:1598-603.
60. Lendeckel U, Dobrev D, Goette A. Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation. British journal of pharmacology 2010;159:1581-3.
61. Milliez P, Deangelis N, Rucker-Martin C et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. European heart journal 2005;26:2193-9. (Pubitemid 41408006)